Alcoholic liver disease (ALD) is one of the leading causes of morbidity and mortality in the U.S. and worldwide. Three hepatologists discussed the management of
ASGE and the ASGE Foundation honored several outstanding gastroenterologists who have contributed to the advancement of GI endoscopy during the 13th Annual Crystal Awards Dinner
Biosimilar medications are beginning to make gains in the U.S. drug market, with the potential for explosive growth in the future. They currently account for
An AASLD symposium on the final day of DDW® 2017 brought together experts from around the world to discuss pharmacological therapies, endoscopic therapies, interventional procedures
Digestive Disease Week® 2017 was one for the books. More than 14,000 GI professionals gathered in Chicago for the world’s premier GI meeting. The four-day
[three_fourth] The ASGE Postgraduate Course at Digestive Disease Week® (DDW) 2018 will feature an expert faculty of master endoscopists, who will review the latest endoscopic
Studies have shown that success in losing weight is affected by how often patients see a health-care professional. Patients benefit from the doctor’s advice and
People fighting obesity often look for treatments that will quickly help them lose weight. Lately, an increasing number are achieving that goal by having intragastric
Two new strategies are emerging to treat GI and other cancers — engineered T cells and immune checkpoint blockade treatments.
Andrew P. Keaveny, MD, FRCPI, FAASLD
Consultant Hepatologist and Medical Director of Liver Transplant, Mayo Clinic, Jacksonville, Florida; Associate Professor of Medicine, Mayo Clinic College of Medicine and Science; Chair, AASLD Annual Meeting Education Committee; Member of the AASLD Maintenance of Certification and Scientific Planning Committees
